• IPA-3: Precision Pak1 Inhibition for Kinase Assays & Recover

  2026-05-08

  IPA-3, a selective and non-ATP competitive Pak1 inhibitor, empowers researchers to interrogate p21-activated kinase signaling with high specificity. Its unique mechanism and versatile solubility profile streamline kinase assays, cancer biology research, and neuroinflammation models where reproducibility and selectivity are paramount.

• Lopinavir (ABT-378): Precision HIV Protease Inhibitor Eviden

  2026-05-07

  Lopinavir (ABT-378) is a high-potency HIV protease inhibitor, designed to maintain efficacy against resistant viral strains and retain activity in serum-rich environments. Robust data support its application in HIV drug resistance studies and antiretroviral therapy development. APExBIO provides validated Lopinavir for research use, with detailed benchmarks and protocol guidance.

• Cy5-UTP in RNA Nanotechnology: Precision Labeling for Advanc

  2026-05-07

  Explore how Cy5-UTP (Cyanine 5-uridine triphosphate) elevates in vitro transcription RNA labeling for advanced nanoparticle and vaccine research. This article uniquely bridges fluorescence labeling with nanotechnological assay optimization, offering insights not covered elsewhere.

• N1-Methyl-Pseudouridine-5'-Triphosphate: RNA Stability & mRN

  2026-05-06

  N1-Methyl-Pseudouridine-5'-Triphosphate (N1-Methylpseudo-UTP) enhances RNA stability and translational efficiency in vitro. This modified nucleoside triphosphate is crucial for mRNA therapeutic development and advanced RNA biology. Peer-reviewed evidence supports its use in improving mRNA-based immunotherapies.

• Mutational Landscape of Myeloma Cell Lines: Insights for Dru

  2026-05-06

  This study delivers the first comprehensive whole-exome characterization of 30 human multiple myeloma cell lines, uncovering key driver mutations and pathway alterations linked to tumor progression and drug resistance. The findings lay a foundation for precision modeling and improved experimental approaches in hematological malignancy research.

• D-Luciferin: Advancing Firefly Luciferase Substrate Workflow

  2026-05-05

  D-Luciferin enables robust, high-sensitivity detection of cellular events through firefly luciferase assays, with unmatched signal fidelity for both in vitro and in vivo applications. This article delivers actionable protocols, advanced troubleshooting, and real-world use-cases—empowering researchers to optimize tumor burden assessment and ATP quantification with confidence.

• Drug-Sensitized Yeast Reveals mTOR Inhibitors: Canagliflozin

  2026-05-05

  The study presents a highly sensitive yeast-based platform for identifying mTOR inhibitors, increasing detection capability for known inhibitors by up to 250-fold. Notably, it demonstrates that Canagliflozin does not inhibit mTOR in this model, clarifying its mechanistic boundaries for metabolic research.

• SHC-1 Inhibition Elevates CFTR Surface Abundance in Epitheli

  2026-05-04

  This study systematically dissects how SHC-1 inhibition enhances CFTR plasma membrane abundance across multiple epithelial cell models. The findings clarify MAPK/SHC-1-dependent regulation of CFTR trafficking, with implications for cystic fibrosis and COPD research.

• Pomalidomide (CC-4047): Applied Workflows in Myeloma Researc

  2026-05-04

  Unlock next-generation hematological malignancy research with Pomalidomide (CC-4047), leveraging its unique cytokine modulation and erythroid differentiation properties. This guide delivers protocol enhancements, troubleshooting strategies, and direct translation of mutational landscape insights for robust, reproducible myeloma and tumor microenvironment studies.

• Salinomycin (SKU A3785): Data-Driven Solutions for HCC Assay

  2026-05-03

  This article delivers a scenario-centric, evidence-backed overview of Salinomycin (SKU A3785) for hepatocellular carcinoma research. It guides biomedical scientists through real-world assay challenges, referencing data on mechanism, reproducibility, and protocol optimization. Practical recommendations are grounded in recent literature and the validated properties of Salinomycin, highlighting its role as a robust polyether ionophore antibiotic.

• VX-745: Mechanistic Insights and Practical Assay Strategies

  2026-05-02

  Explore the advanced mechanism of VX-745, a potent p38α MAPK inhibitor, and discover how new conformational insights enable optimized experimental design. This article provides unique, practical strategies for leveraging VX-745 in inflammation and multiple myeloma research.

• Okadaic acid: Practical Guide for PP1/PP2A Inhibition Workfl

  2026-05-02

  Okadaic acid is a potent marine-derived inhibitor of serine/threonine protein phosphatases, primarily used for the selective inhibition of PP1 and PP2A in cell signaling and apoptosis research. It is ideal for experiments requiring precise dissection of phosphorylation-dependent pathways but should not be used in studies where broad-spectrum phosphatase inhibition or off-target effects cannot be controlled.

• Meropenem in Resistance Dynamics: Genomic Insights for Trans

  2026-05-01

  Discover how Meropenem, an ultra-broad-spectrum β-lactam antibiotic carbapenem, informs advanced translational research through the lens of carbapenemase gene dynamics. This article uniquely connects genomic resistance data to practical assay decisions, differentiating itself from existing scenario-driven or mechanistic guides.

• nor-Binaltorphimine Dihydrochloride: Decoding KOR Circuits i

  2026-04-30

  Explore the nuanced role of nor-Binaltorphimine dihydrochloride as a κ-opioid receptor antagonist in unraveling pain modulation circuits. This article offers a mechanistic and assay-focused perspective, grounded in recent brain-to-spinal circuit discoveries.

• Triiodothyronine (T3): Powering Translational Metabolic Rese

  2026-04-30

  This thought-leadership article provides translational researchers with a nuanced exploration of Triiodothyronine (T3)—its mechanistic role in adipocyte thermogenesis, strategic value in metabolic disorder research, and best practices for robust experimental design. By synthesizing mechanistic evidence from recent literature with APExBIO’s high-purity T3 product intelligence, the piece offers actionable insights for advancing thyroid hormone signaling pathway studies and elevating research reproducibility.

408 records 16/28 page Previous Next First page 上5页 1617181920 下5页 Last page